Correlation Between Apellis Pharmaceuticals and Prime Medicine,
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Prime Medicine, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Prime Medicine, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Prime Medicine, Common, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Prime Medicine, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Prime Medicine,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Prime Medicine,.
Diversification Opportunities for Apellis Pharmaceuticals and Prime Medicine,
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Apellis and Prime is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Prime Medicine, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Medicine, Common and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Prime Medicine,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Medicine, Common has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Prime Medicine, go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Prime Medicine,
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 0.91 times more return on investment than Prime Medicine,. However, Apellis Pharmaceuticals is 1.1 times less risky than Prime Medicine,. It trades about 0.15 of its potential returns per unit of risk. Prime Medicine, Common is currently generating about -0.26 per unit of risk. If you would invest 2,734 in Apellis Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 343.00 from holding Apellis Pharmaceuticals or generate 12.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Prime Medicine, Common
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Prime Medicine, Common |
Apellis Pharmaceuticals and Prime Medicine, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Prime Medicine,
The main advantage of trading using opposite Apellis Pharmaceuticals and Prime Medicine, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Prime Medicine, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Medicine, will offset losses from the drop in Prime Medicine,'s long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
| Prime Medicine, vs. Beam Therapeutics | Prime Medicine, vs. Caribou Biosciences | Prime Medicine, vs. Intellia Therapeutics | Prime Medicine, vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |